Increased frequency of disease-causing MYH mutations in colon cancer families.

The genetic factors that cause clustering of colorectal cancers (CRCs) other than mutations in the mismatch repair (MMR) genes are not well understood. Clustering in families who lack MMR gene mutations may be attributable to low-penetrance mutations. Hypothetically, mono-allelic MYH mutations could contribute to the risk of CRC in these families. Using Fisher's exact test and logistic regression, we compared the frequency of the known disease-causing MYH mutations Y165C, G382D and 466delE in 137 probands (117 cases with CRC and 20 cases diagnosed on the basis of adenomatous polyps only) from families with three or more CRCs but negative for mutations in the MMR genes and in 967 healthy controls with comparable ethnic backgrounds. Of 137 cases, 6 (4.4%) carried mono-allelic MYH mutations compared with 16 of 967 (1.6%) controls. In addition, three bi-allelic MYH mutation carriers, who eventually developed MYH-associated polyposis, were also identified in families with pedigree structures consistent with dominant inheritance of CRC susceptibility. By Fisher's exact tests, there was a statistically different frequency of cases with any MYH mutation (mono- or bi-allelic carriers; P-value = 0.002) and of cases with mono-allelic MYH mutation (P = 0.04) compared with the controls. Using a logistic regression model, the unadjusted odds ratio associated with any MYH mutation was 4.14 (P-value < 0.001); for mono-allelic carriers, it was 2.79 (P-value = 0.04). Adjusting for ethnic backgrounds, gender and age, the odds ratio associated with any disease-causing MYH mutation was 3.23 (P-value = 0.01); for mono-allelic carriers, it was 1.99 (P-value = 0.20). Overall, the results support previous studies suggesting that mono-allelic mutations of MYH constitute low-penetrance CRC-causing alleles. These data further support a model in which low-penetrance alleles are enriched in MMR gene mutation-negative CRC families.

[1]  J. Hopper,et al.  Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  D. Chung,et al.  Correlation of polyp number and family history of colon cancer with germline MYH mutations. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  J. Prendergast,et al.  Germline susceptibility to colorectal cancer due to base-excision repair gene defects. , 2005, American journal of human genetics.

[4]  A. Lindblom,et al.  Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. , 2005, Genetic testing.

[5]  R. Scott,et al.  Frequency of the Common MYH Mutations (G382D and Y165C) in MMR Mutation Positive and Negative HNPCC Patients , 2005, Hereditary cancer in clinical practice.

[6]  A. de la Chapelle,et al.  TGFBR1*6A may contribute to hereditary colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Offit,et al.  Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH , 2005, International journal of cancer.

[8]  A. Tenesa,et al.  Re: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. , 2005, Journal of the National Cancer Institute.

[9]  W. Gerald,et al.  Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in Hereditary Colorectal Neoplasms , 2005, The American journal of surgical pathology.

[10]  A. Chapelle,et al.  Genetic predisposition to colorectal cancer , 2004, Nature Reviews Cancer.

[11]  J. Peto,et al.  The search for low-penetrance cancer susceptibility alleles , 2004, Oncogene.

[12]  S. Thibodeau,et al.  MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. , 2004, Gastroenterology.

[13]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[14]  P. Radice,et al.  Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas , 2004, International journal of cancer.

[15]  J. Peto,et al.  Comprehensive analysis of the contribution of germline MYH variation to early‐onset colorectal cancer , 2004, International journal of cancer.

[16]  K. Offit,et al.  MSH6 germline mutations are rare in colorectal cancer families , 2003, International journal of cancer.

[17]  L. Lipton,et al.  Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. , 2003, The American journal of pathology.

[18]  L. Lipton,et al.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.

[19]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[20]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[21]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[22]  H. Ostrer,et al.  TβR-I(6A) Is a Candidate Tumor Susceptibility Allele , 1999 .

[23]  A. de la Chapelle,et al.  Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.

[24]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[25]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[26]  P. Møller,et al.  Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. , 1997, American journal of human genetics.

[27]  M. Schwab,et al.  Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. , 1996, Human molecular genetics.

[28]  J. Mecklin,et al.  The International Collaborative Group on HNPCC. , 1994, Anticancer research.

[29]  G. Thomas,et al.  [Genetic predisposition to colorectal cancer]. , 1993, Annales de gastroenterologie et d'hepatologie.

[30]  H. Lynch,et al.  Genetic factors and colorectal cancer in Ashkenazi Jews , 2004, Familial Cancer.

[31]  J. Knight,et al.  Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. , 2004, Journal of the National Cancer Institute.

[32]  The Polish Breast Cancer Consortium Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .

[33]  H. Lynch,et al.  GENETIC SUSCEPTIBILITY TO NONPOLYPOSIS COLORECTAL CANCER , 1999 .

[34]  H. Ostrer,et al.  TbetaR-I(6A) is a candidate tumor susceptibility allele. , 1999, Cancer research.

[35]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[36]  J. Mecklin,et al.  Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families , 1993, Diseases of the colon and rectum.